Israel - English - Ministry of Health

bayer israel ltd - nifedipine - tablets prolonged release - nifedipine 20 mg - nifedipine - nifedipine - chronic stable angina, hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nifedipine -

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nifedipine -

United States - English - NLM (National Library of Medicine)

almatica pharma inc. - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg - concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions, drug interactions .)  nifedipine must not be used in cases of cardiogenic shock. adalat is contraindicated in patients with a known hypersensitivity to any component of the tablet.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nifedipine, quantity: 30 mg - tablet, modified release - excipient ingredients: magnesium stearate; cellulose acetate; polyethylene oxide; macrogol 3350; hypromellose; iron oxide red; sodium chloride; titanium dioxide; propylene glycol; hyprolose; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - indications: nifedipine is indicated for: 1. the treatment of mild to moderate hypertension. 2. the prophylaxis of chronic stable angina pectoris.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nifedipine -

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nifedipine -

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 90 mg - concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions, drug interactions .)  nifedipine must not be used in cases of cardiogenic shock. adalat is contraindicated in patients with a known hypersensitivity to any component of the tablet.

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - nifedipine atenolol - capsule - 20mg/50 mg milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - nifedipine atenolol - capsule - 20mg/50 mg milligram